Lung Persistence, Biodegradation, and Elimination of Graphene-Based Materials are Predominantly Size-Dependent and Mediated by Alveolar Phagocytes.

Graphene-based materials (GBMs) have promising applications in various sectors, including pulmonary nanomedicine. Nevertheless, the influence of GBM physicochemical characteristics on their fate and impact in lung has not been thoroughly addressed. To fill this gap, the biological response, distribution, and bio-persistence of four different GBMs in mouse lungs up to 28 days after single oropharyngeal aspiration are investigated. None of the GBMs, varying in size (large versus small) and carbon to oxygen ratio as well as thickness (few-layers graphene (FLG) versus thin graphene oxide (GO)), induce a strong pulmonary immune response. However, recruited neutrophils internalize nanosheets better and degrade GBMs faster than macrophages, revealing their crucial role in the elimination of small GBMs. In contrast, large GO sheets induce more damages due to a hindered degradation and long-term persistence in macrophages. Overall, small dimensions appear to be a leading feature in the design of safe GBM pulmonary nanovectors due to an enhanced degradation in phagocytes and a faster clearance from the lungs for small GBMs. Thickness also plays an important role, since decreased material loading in alveolar phagocytes and faster elimination are found for FLGs compared to thinner GOs. These results are important for designing safer-by-design GBMs for biomedical application.

[1]  Kostas Kostarelos,et al.  Lung recovery from DNA damage induced by graphene oxide is dependent on size, dose and inflammation profile , 2022, Particle and Fibre Toxicology.

[2]  Helinor J Johnston,et al.  Grouping MWCNTs based on their similar potential to cause pulmonary hazard after inhalation: a case-study , 2022, Particle and fibre toxicology.

[3]  M. Prato,et al.  Hazard assessment of abraded thermoplastic composites reinforced with reduced graphene oxide. , 2022, Journal of hazardous materials.

[4]  Kostas Kostarelos,et al.  Innate but Not Adaptive Immunity Regulates Lung Recovery from Chronic Exposure to Graphene Oxide Nanosheets , 2022, Advanced science.

[5]  Xiaohui Xie,et al.  Use of Nanoformulation to Target Macrophages for Disease Treatment , 2021, Advanced Functional Materials.

[6]  A. Bianco,et al.  How macrophages respond to two-dimensional materials: a critical overview focusing on toxicity , 2021, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.

[7]  S. Aryal,et al.  Biogenic and biomimetic nanocarrier-based interventions: focus on intracellular infections. , 2021, Nanomedicine.

[8]  Liming Wang,et al.  Molybdenum derived from nanomaterials incorporates into molybdenum enzymes and affects their activities in vivo , 2021, Nature Nanotechnology.

[9]  A. Bianco,et al.  Toxicological evaluation of highly water dispersible few-layer graphene in vivo , 2020, Carbon.

[10]  Jyh-Ping Chen,et al.  Mechanism of Nanoformulated Graphene Oxide-Mediated Human Neutrophil Activation. , 2020, ACS applied materials & interfaces.

[11]  A. Bianco,et al.  Comparative Effects of Graphene and Molybdenum Disulfide on Human Macrophage Toxicity. , 2020, Small.

[12]  S. Haigh,et al.  Splenic Capture and In Vivo Intracellular Biodegradation of Biological-Grade Graphene Oxide Sheets , 2020, ACS nano.

[13]  B. Fadeel,et al.  Size‐Dependent Pulmonary Impact of Thin Graphene Oxide Sheets in Mice: Toward Safe‐by‐Design , 2020, Advanced science.

[14]  Yue Yu,et al.  Rational chemical multifunctionalization of graphene interface enhances targeting cancer therapy. , 2020, Angewandte Chemie.

[15]  B. K. Gupta,et al.  Probing number of layers and quality assessment of mechanically exfoliated graphene via Raman fingerprint , 2020 .

[16]  Ardemis A. Boghossian,et al.  Banning carbon nanotubes would be scientifically unjustified and damaging to innovation , 2020, Nature Nanotechnology.

[17]  Steffen Foss Hansen,et al.  Carbon nanotubes added to the SIN List as a nanomaterial of Very High Concern , 2020, Nature Nanotechnology.

[18]  Bengt Fadeel,et al.  Nano-bio interactions: a neutrophil-centric view , 2019, Cell Death & Disease.

[19]  Bengt Fadeel,et al.  Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment. , 2018, ACS nano.

[20]  Bengt Fadeel,et al.  Degradation of Single-Layer and Few-Layer Graphene by Neutrophil Myeloperoxidase. , 2018, Angewandte Chemie.

[21]  B. Fadeel,et al.  A blueprint for the synthesis and characterisation of thin graphene oxide with controlled lateral dimensions for biomedicine , 2018 .

[22]  L. Ramakrishnan,et al.  The Formation and Function of Granulomas. , 2018, Annual review of immunology.

[23]  Bengt Fadeel,et al.  Graphene Oxide Elicits Membrane Lipid Changes and Neutrophil Extracellular Trap Formation , 2018 .

[24]  Tian Xia,et al.  Surface Oxidation of Graphene Oxide Determines Membrane Damage, Lipid Peroxidation, and Cytotoxicity in Macrophages in a Pulmonary Toxicity Model. , 2018, ACS nano.

[25]  Kostas Kostarelos,et al.  Live Imaging of Label-Free Graphene Oxide Reveals Critical Factors Causing Oxidative-Stress-Mediated Cellular Responses. , 2017, ACS nano.

[26]  I. Annesi-Maesano,et al.  Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris , 2017, European Respiratory Journal.

[27]  U. Vogel,et al.  Differences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxide , 2017, PloS one.

[28]  T. Park,et al.  Diverse Applications of Nanomedicine , 2017, ACS nano.

[29]  Sang Jin Lee,et al.  Pulmonary persistence of graphene nanoplatelets may disturb physiological and immunological homeostasis , 2017, Journal of applied toxicology : JAT.

[30]  Zhongfan Liu,et al.  Size and time dependent internalization of label-free nano-graphene oxide in human macrophages , 2017, Nano Research.

[31]  Bengt Fadeel,et al.  Detection of Endotoxin Contamination of Graphene Based Materials Using the TNF-α Expression Test and Guidelines for Endotoxin-Free Graphene Oxide Production , 2016, PloS one.

[32]  Anna Huttenlocher,et al.  Neutrophil migration in infection and wound repair: going forward in reverse , 2016, Nature Reviews Immunology.

[33]  Jong Seong Lee,et al.  28-Day inhalation toxicity of graphene nanoplatelets in Sprague-Dawley rats , 2016, Nanotoxicology.

[34]  Bengt Fadeel,et al.  Biological interactions of carbon-based nanomaterials: From coronation to degradation. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[35]  E. Petersen,et al.  Biodistribution and toxicity of radio-labeled few layer graphene in mice after intratracheal instillation , 2015, Particle and Fibre Toxicology.

[36]  Rui Liu,et al.  Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-inflammatory Responses in Cells and Animals. , 2015, ACS nano.

[37]  Alberto Bianco,et al.  Carbon Nanotube Degradation in Macrophages: Live Nanoscale Monitoring and Understanding of Biological Pathway. , 2015, ACS nano.

[38]  Dong‐Wan Kim,et al.  Toxic response of graphene nanoplatelets in vivo and in vitro , 2015, Archives of Toxicology.

[39]  Vincenzo Palermo,et al.  Dispersibility-Dependent Biodegradation of Graphene Oxide by Myeloperoxidase. , 2015, Small.

[40]  Hamidreza Ghandehari,et al.  Nanoparticle Uptake: The Phagocyte Problem. , 2015, Nano today.

[41]  Meiying Wang,et al.  Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials. , 2015, ACS nano.

[42]  Jae Hoon Shin,et al.  5-Day repeated inhalation and 28-day post-exposure study of graphene , 2015, Nanotoxicology.

[43]  Vasileios Koutsos,et al.  Minimal oxidation and inflammogenicity of pristine graphene with residence in the lung , 2014, Nanotoxicology.

[44]  K Kostarelos,et al.  Graphene for multi-functional synthetic biology: the last 'zeitgeist' in nanomedicine. , 2014, Bioorganic & medicinal chemistry letters.

[45]  Yong Zhao,et al.  Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo. , 2013, Advanced drug delivery reviews.

[46]  Tatyana Chernova,et al.  Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences. , 2013, Advanced drug delivery reviews.

[47]  Abhilash Sasidharan,et al.  Confocal Raman Imaging Study Showing Macrophage Mediated Biodegradation of Graphene In Vivo , 2013, Advanced healthcare materials.

[48]  Moreno Meneghetti,et al.  Evidencing the mask effect of graphene oxide: a comparative study on primary human and murine phagocytic cells. , 2013, Nanoscale.

[49]  K. Donaldson,et al.  Use of back-scatter electron signals to visualise cell/nanowires interactions in vitro and in vivo; frustrated phagocytosis of long fibres in macrophages and compartmentalisation in mesothelial cells in vivo , 2012, Particle and Fibre Toxicology.

[50]  S. A. Hasan,et al.  A natural vanishing act: the enzyme-catalyzed degradation of carbon nanomaterials. , 2012, Accounts of chemical research.

[51]  Bengt Fadeel,et al.  Impaired Clearance and Enhanced Pulmonary Inflammatory/Fibrotic Response to Carbon Nanotubes in Myeloperoxidase-Deficient Mice , 2012, PloS one.

[52]  Ken Donaldson,et al.  Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. , 2012, ACS nano.

[53]  Mark C Hersam,et al.  Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. , 2011, Nano letters.

[54]  Joel G Pounds,et al.  ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.

[55]  Judith Klein-Seetharaman,et al.  Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. , 2010, Nature nanotechnology.

[56]  Craig A. Poland,et al.  Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma , 2010, Particle and Fibre Toxicology.

[57]  R. Löbenberg,et al.  Targeted delivery of nanoparticles for the treatment of lung diseases. , 2008, Advanced drug delivery reviews.